Energy & environment · 01/07/2003Updated: 10/17/2026 · 1 min read
U.S. Nuclear Regulatory Commission Approves License Amendment for Merck & Company's Byproduct Material
Summary
The U.S. Nuclear Regulatory Commission has issued a Finding of No Significant Impact for a license amendment related to Merck & Company's Byproduct Material License No. 45-03302-01, allowing the company to proceed with the amendment.
Original source language: Federal Register — Nuclear Regulatory CommissionOpen original release →